| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 277,978 | 271,996 | 302,350 | 276,740 | | Cost of Revenue | 116,030 | 114,281 | 128,863 | 121,494 | | | Gross Profit | 161,948 | 157,715 | 173,487 | 155,246 | | | Operating Expenses | | Research Development | 23,232 | 22,409 | 21,668 | 21,639 | | Selling General and Administrative | 54,055 | 51,940 | 63,741 | 56,973 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 84,661 | 83,366 | 88,078 | 76,634 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,092) | 1,024 | 10,756 | 4,972 | | Earnings Before Interest And Taxes | 83,569 | 84,390 | 98,834 | 81,606 | | Interest Expense | 1,727 | 2,778 | 2,107 | 2,110 | | Income Before Tax | 81,842 | 81,612 | 96,727 | 79,496 | | Income Tax Expense | 26,189 | 27,340 | 31,404 | 23,863 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 55,653 | 54,272 | 65,323 | 55,633 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 55,653 | 54,272 | 65,323 | 55,633 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $55,653 | $54,272 | $65,323 | $55,633 |
|
0.09% Nasdaq 
0.27%
Income Statement
